Dirk Weber

Dirk Weber serves as the Executive Director of Medical Affairs for Europe at BeiGene since November 2019, bringing extensive experience in the biopharmaceutical and oncology sectors. Previous roles include membership on the Scientific Advisory Boards for TOLREMO therapeutics AG and Elthera AG, as well as medical leadership positions at Aurealis Pharma AG and Cellestia Biotech AG, where innovative cancer therapies were developed. Dirk Weber's background also includes directorial roles at Takeda Pharmaceuticals focusing on Emerging Markets and significant contributions to clinical programs at Novartis, specifically in breast and ovarian cancer. Education credentials include an MD from Georgetown University School of Medicine and an MD in Oncology from Kiel University.